The Medication Safety Self Assessment^® for Antithrombotic Therapy in Australian Hospitals (MSSA-AT) is designed to:

Heighten awareness of items related to the safe use of antithrombotic agents; and create a baseline of hospital efforts to enhance safety with these agents and evaluate these efforts over time.

The self assessment is divided into eight key elements that significantly influence safe use of antithrombotic agents. Each key element is defined by one or more core characteristics of a safe medication system. Self assessment items are provided to help you evaluate your success with achieving each core characteristic.

The Medication Safety Self Assessment^® for Antithrombotic Therapy in Australian Hospitals (MSSA-AT) is subject to copyright in the name of ISMP and has been adapted by NSW TAG with the permission of ISMP for use in the Australian health care environment. It may not be used in whole or in part for any other purpose or by any other entity except for self assessment by Australian hospitals.

ISMP and NSWTAG are not standards setting organisations. As such, the self assessment items in this document are not purported to represent a minimum standard of practice and should not be considered as such. In fact, some of the self assessment criteria represent innovative practices and system enhancements that are not widely implemented in most hospitals today. However, their value in reducing errors is grounded in scientific research and expert analysis of medication errors and their causes.

For more information on the use of the Medication Safety Self Assessment for Australian Hospitals and Medication Safety Self Assessment for Antithrombotic Therapy in Australian Hospitals please send your email enquiry to mssa@cec.health.nsw.gov.au.